Details of the Drug Reposition | DrugMAP

General Information of This Drug (ID: DMQZBXI)

Drug Name	Calaspargase pegol DMQZBXI
Synonyms	UNII-T9FVH03HMZ; T9FVH03HMZ; Calaspargase pegol [USAN:INN]; EZN-2285
Drug Type	Antibody

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

1 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Acute lymphocytic leukaemia	DISPX75S	2B33.3	Approved	[1]
------------------------------------------------------------------------------------

1 Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Acute lymphoblastic leukaemia	DIS87TGM	2A85	Phase 3	[2]
------------------------------------------------------------------------------------

References

1	Pharmacokinetic and pharmacodynamic properties of calaspargase pegol Escherichia coli L-asparaginase in the treatment of patients with acute lymphoblastic leukemia: results from Children's Oncology Group Study AALL07P4. J Clin Oncol. 2014 Dec 1;32(34):3874-82.
2	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034060)